Results 201 to 210 of about 7,421,514 (390)

In vitro models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of CRISPR perturbations

open access: yesMolecular Oncology, EarlyView.
Development of therapies targeting cancer‐associated fibroblasts (CAFs) necessitates preclinical model systems that faithfully represent CAF–tumor biology. We established an in vitro coculture system of patient‐derived pancreatic CAFs and tumor cell lines and demonstrated its recapitulation of primary CAF–tumor biology with single‐cell transcriptomics ...
Elysia Saputra   +10 more
wiley   +1 more source

Forensic Dating of Venous Thromboembolism: Advances in Histological, Immunohistochemical and Molecular Markers. [PDF]

open access: yesDiagnostics (Basel)
Forzese E   +8 more
europepmc   +1 more source

Immunologic and molecular analysis for low-grade malt lymphoma: Are there any useful markers to predict the outcome after Helicobacter pylori irradication? [PDF]

open access: bronze, 1998
Yumi Matsushima   +8 more
openalex   +1 more source

Effect of chemotherapy on passenger mutations in metastatic colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Changes in passenger mutation load and predicted immunotherapy response after chemotherapy treatment. Tumor cells rich with passenger mutations have increased sensitivity to chemotherapy. Correlation of passenger mutations with neoantigen load suggests highly mutated clones promote a more effective response to immunotherapy, and therefore, first‐line ...
Marium T. Siddiqui   +6 more
wiley   +1 more source

Therapeutic efficacy of artemether-lumefantrine and molecular markers of antimalarial resistance in Niger, 2022. [PDF]

open access: yesMalar J
Laminou IM   +15 more
europepmc   +1 more source

Using molecular markers to assist in the selection of the rice blast resistance genes Pi1 , Pi2 , and Pi-ta in rice wide compatibility restorer lines

open access: gold
Hailong Yang   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy